Cargando…

Corrigendum to “Upregulated Expression of Intestinal Antimicrobial Peptide HD5 Associated with Renal Function in IgA Nephropathy”

Detalles Bibliográficos
Autores principales:	Feng, Shaozhen, Zhong, Zhong, Fan, Jinjin, Li, Xiaoyan, Shi, Dianchun, Jiang, Lanping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9402380/ https://www.ncbi.nlm.nih.gov/pubmed/36033832 http://dx.doi.org/10.1155/2022/9797825

Ejemplares similares

Upregulated Expression of Intestinal Antimicrobial Peptide HD5 Associated with Renal Function in IgA Nephropathy
por: Feng, Shaozhen, et al.
Publicado: (2020)

RhoA vesicle trafficking–mediated transglutaminase 2 membrane translocation promotes IgA1 mesangial deposition in IgA nephropathy
por: Zhong, Zhong, et al.
Publicado: (2023)

Corrigendum to “The Association of TNF-Alpha Inhibitors and Development of IgA Nephropathy in Patients with Rheumatoid Arthritis and Diabetes”
por: Premužić, Vedran, et al.
Publicado: (2020)

Immunosuppressive agents versus steroids in the treatment of IgA nephropathy-induced proteinuria: A meta-analysis
por: Liu, Yanli, et al.
Publicado: (2019)

Association between urinary VEGFA and renal pathology of IgA nephropathy patients
por: Feng, Shaozhen, et al.
Publicado: (2021)

Landscape of intestinal microbiota in patients with IgA nephropathy, IgA vasculitis and Kawasaki disease
por: Hu, Xueli, et al.
Publicado: (2022)

Corrigendum to Shi M, Yu S, Ouyang Y, et al. Increased lifetime risk of ESRD in familial IgA nephropathy. Kidney Int Rep. 2021;6:91-100.
Publicado: (2021)

Corrigendum: Concurrent IgA nephropathy and membranous nephropathy, is it an overlap syndrome?
por: He, Jia-Wei, et al.
Publicado: (2023)

Diagnosis and treatment of IgA nephropathy and IgA vasculitis nephritis in Chinese children
por: Zhong, Xuhui, et al.
Publicado: (2022)

Corrigendum to “HD-13 Induces Swine Pneumonia Progression via Activation of TLR9”
por: Liu, Jing, et al.
Publicado: (2022)

The Role of IgA in the Pathogenesis of IgA Nephropathy
por: Perše, Martina, et al.
Publicado: (2019)

Use of low-dose sulodexide in IgA nephropathy patients on renin–angiotensin system blockades [Volume 31, Issue 3, September 2012, Pages 163–169]
por: Yun Yang, Byeong, et al.
Publicado: (2013)

Zonulin, as a marker of intestinal permeability, is elevated in IgA nephropathy and IgA vasculitis with nephritis
por: Li, Qianqian, et al.
Publicado: (2022)

IgA Vasculitis and IgA Nephropathy: Same Disease?
por: Pillebout, Evangeline
Publicado: (2021)

Experimental IgA nephropathy
Publicado: (1979)

Sulodexide in IgA nephropathy
Publicado: (2013)

T lymphocytes in IgA nephropathy
por: Tang, Yuyan, et al.
Publicado: (2020)

Secondary IgA Nephropathy Shares the Same Immune Features With Primary IgA Nephropathy
por: Wang, Manliu, et al.
Publicado: (2019)

Validation of the International IgA Nephropathy Prediction Tool in the Greek Registry of IgA Nephropathy
por: Papasotiriou, Marios, et al.
Publicado: (2022)

Current understanding of IgA antibodies in the pathogenesis of IgA nephropathy
por: Nihei, Yoshihito, et al.
Publicado: (2023)

Serum Levels of Joining Chain-Containing IgA1 Are Not Elevated in Patients with IgA Nephropathy
por: Li, Guanhong, et al.
Publicado: (2019)

The possible involvement of intestine-derived IgA(1): a case of IgA nephropathy associated with Crohn’s disease
por: Terasaka, Tomohiro, et al.
Publicado: (2016)

Gut Dysbiosis and Intestinal Barrier Dysfunction Promotes IgA Nephropathy by Increasing the Production of Gd-IgA1
por: Tang, Yuyan, et al.
Publicado: (2022)

Astragalus membranaceus up-regulate Cosmc expression and reverse IgA dys-glycosylation in IgA nephropathy
por: Ji, Ling, et al.
Publicado: (2014)

IgA Nephropathy Genetic Risk Score to Estimate the Prevalence of IgA Nephropathy in UK Biobank
por: Sukcharoen, Kittiya, et al.
Publicado: (2020)

Secondary IgA Nephropathy and IgA-Associated Nephropathy: A Systematic Review of Case Reports
por: Tota, Maciej, et al.
Publicado: (2023)

Corrigendum to “Upregulation of TIPE1 in tubular epithelial cell aggravates diabetic nephropathy by disrupting PHB2 mediated mitophagy” [Redox Biol. 50 (2022) 2213–2317/102260]
por: Liu, L., et al.
Publicado: (2022)

Thrombotic Microangiopathy in IgA Nephropathy
por: Nasri, Hamid
Publicado: (2013)

Role of complement in IgA nephropathy
por: Daha, Mohamed R., et al.
Publicado: (2015)

Nutcracker phenomenon in IgA nephropathy
por: Imai, Naohiko, et al.
Publicado: (2014)

Idiopathic erythrocytosis in IgA nephropathy
por: Mahesh, E., et al.
Publicado: (2017)

Case Presentation – IgA Nephropathy
por: Williams, David L.
Publicado: (2005)

Tuberculosis-associated IgA nephropathy
por: Wang, Yamei, et al.
Publicado: (2018)

IgA nephropathy with leucocytoclastic vasculitis
por: Wei, Lin-Yan, et al.
Publicado: (2018)

Palmoplantar pustulosis and IgA nephropathy
por: Shimamura, Yoshinosuke, et al.
Publicado: (2018)

Spondyloarthritis-Associated IgA Nephropathy
por: Champtiaux, Nicolas, et al.
Publicado: (2020)

Immunological Pattern in IgA Nephropathy
por: Esteve Cols, Clara, et al.
Publicado: (2020)

MicroRNAs in IgA nephropathy
por: Yao, Xingchen, et al.
Publicado: (2021)

Complement activation in IgA nephropathy
por: Medjeral-Thomas, Nicholas R., et al.
Publicado: (2021)

Current treatment of IgA nephropathy
por: Floege, Jürgen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_m13voum3dd5tnr1jgnf275uqhi